Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating expenses
Research and development	$ 5,783,865	$ 5,484,145
General and administrative	2,138,241	1,500,554
Total operating expenses	7,922,106	6,984,699
Loss from operations	(7,922,106)	(6,984,699)
Other income (expense)
Gain on remeasurement of warrant liabilities	456,177	11,126
Interest expense	(3,487)	(7,655)
Interest income	173,098	147,011
Other expense	(129,894)	(14,494)
Total other income, net	495,894	135,988
Loss before provision for income taxes	(7,426,212)	(6,848,711)
Provision for income taxes	7,396	2,978
Net loss	$ (7,433,608)	$ (6,851,689)
Net loss per share:
Basic and diluted (in dollars per share)	$ (0.25)	$ (0.31)
Weighted average shares outstanding
Basic and diluted (in shares)	29,887,325	21,833,598